The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena
about
sameAs
Anticomplementary activity of Fusobacterium polymorphum in normal and C4-deficient sources of guinea pig complementControl of the amplification convertase of complement by the plasma protein beta1HParoxysmal nocturnal hemoglobinuria from bench to bedsideAn alternative mechanism for the properdin systemEarly Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune DiseasesSystemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical PathwayProperdin: a tightly regulated critical inflammatory modulatorIncomplete cold antibodies role of complement in sensitization to antiglobulin serum by potentially haemolytic antibodiesAnalysis of the interactions between properdin, the third component of complement (C3), and its physiological activation productsThe extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q.Complement in glomerular injury.A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples.Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat modelFluid phase recognition molecules in neutrophil-dependent immune responses.Response of mice to the inoculations of both Candida albicans and Escherichia coli. I. The enhancement phenomenon.A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia.THE INITIATION AND ENHANCEMENT OF HUMAN RED CELL LYSIS BY ACTIVATORS OF THE FIRST COMPONENT OF COMPLEMENT AND BY FIRST COMPONENT ESTERASE; STUDIES USING NORMAL RED CELLS AND RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.Alterations in lung macrophage antimicrobial activity associated with viral pneumonia.An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.Enhancement of resistance to infectious diseases by oral administration of brewer's yeast.Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption.Historical aspects of paroxysmal nocturnal haemoglobinuria: 'defining the disease'.Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury.Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complementSerum factors and the reticuloendothelial uptake of Staphylococcus aureus. II. Role of a zymosan-adsorbable serum opsonin.Properdin homeostasis requires turnover of the alternative complement pathwayMeningococcal disease and the complement system.The complement system: history, pathways, cascade and inhibitors.Effect of complement fixation on the release of lysosomal enzymes from rabbit alveolar macrophages.Fatal anaphylaxis-like reaction induced by yeast mannans in nonsensitized mice.Complete absence of the third component of complement in man.Metabolism of properdin in normal subjects and patients with renal disease.Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis.Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.The association of respiratory infection, recurrent hematuria, and focal glomerulonephritis with activation of the complement system in the cold.Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoidAssembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosisNew insights of an old defense system: structure, function, and clinical relevance of the complement system.
P2860
Q24561393-DC480D0B-1799-4007-9337-BFE01AD514ACQ24561671-D6F69FE4-FDDD-4542-98BF-27E4C67B6E54Q24599629-DE1A39F0-8204-4E57-894D-35AFF98C1A9DQ24680386-B985AA58-EEB8-496A-A55A-0F369E530523Q26766486-9AF09F0D-BB13-47C0-9273-DAECA199D789Q26768534-27207A75-3664-457C-9DD7-ACC4000EFF69Q28069187-614257D5-030C-4D5D-BD32-C5A9EE56563EQ28214079-97B52919-C4A8-44A7-A2D7-26F257E62575Q28610971-2F74F29A-6C1F-412C-8E5D-6BDC7266C2B9Q33220400-3AF8C34A-38FC-4AAF-8B11-F367EFC82D21Q33376840-5874D983-E0DA-4A59-ACC2-2933F66BB724Q33568131-68A1A81C-2E13-421E-BD6A-326A0AC12C09Q33596128-CECBFA9B-081F-4250-9276-1D9FF0013D2FQ33602953-37626DA8-0617-45FE-84BD-3F9DA0FAE2F6Q33626308-237B7DB2-1524-423E-B551-53C27E9C40EAQ33966795-F7C1ED84-D2E2-4858-A377-2E84A661A123Q34005453-16F2AF0D-A0A7-40EE-B1FD-F1C5DBE66D00Q34058375-B03E3ECB-2184-4FEE-8657-33F7A6FCBCECQ34077836-F6F25E07-C31F-4967-A048-82A745A0632BQ34096887-B04C64FD-3B15-422E-8F7C-F217724219A9Q34105747-B31C97E5-39C2-418E-BAF2-E20D28BF31A3Q34107195-F901441E-923D-43E4-847E-A858E14DFB5CQ34114648-0335A26E-D89F-4FCC-A6B6-AD8F8850D6F4Q34120817-346717A3-1481-40DA-AF4C-AD8363B9482CQ34162118-E30E0DEF-9FE9-47A6-9BEC-ED2D8FD8A141Q34172424-06EF0543-C1A9-4335-997A-27473E070394Q34179463-9F8038BD-7FC7-41C0-9940-05B6FAE8EE25Q34320277-46AC9A51-8F3A-4B1C-95D8-C4EDE8A66E28Q34376170-A894B385-21DC-413B-B35E-7DD3E43C345FQ34412336-95A0B085-C160-48AE-97F1-4FEE33A302F4Q34464146-C782EEAB-48CD-4E18-AE68-1C9B0B08018AQ34468182-DCA918B4-9C9C-4C01-B896-9FF8535BCBC1Q34481903-E9E15F60-81F1-439F-BDFB-98E14604A02CQ34482222-64FF5962-D009-414D-8615-B8935EA93474Q34500930-B8573DEE-7A82-4A10-8B55-97BB6FD5DC11Q34503864-5F3FF560-66EC-41BC-A474-0E845E6B0AE7Q34507682-7709B0BD-FB73-44B9-A5F1-7E48451F6ED3Q34508179-59EC1B6C-304F-4919-9325-FACFDD5503B7Q34651178-0DC6815D-99C8-42A0-85A9-7902B2311216Q34699496-B7280F0D-F3DC-4AD6-B198-BA98C3A7B361
P2860
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena
description
1954 nî lūn-bûn
@nan
1954 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1954 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1954年の論文
@ja
1954年論文
@yue
1954年論文
@zh-hant
1954年論文
@zh-hk
1954年論文
@zh-mo
1954年論文
@zh-tw
1954年论文
@wuu
name
The properdin system and immun ...... d its role in immune phenomena
@ast
The properdin system and immun ...... d its role in immune phenomena
@en
The properdin system and immun ...... d its role in immune phenomena
@nl
type
label
The properdin system and immun ...... d its role in immune phenomena
@ast
The properdin system and immun ...... d its role in immune phenomena
@en
The properdin system and immun ...... d its role in immune phenomena
@nl
prefLabel
The properdin system and immun ...... d its role in immune phenomena
@ast
The properdin system and immun ...... d its role in immune phenomena
@en
The properdin system and immun ...... d its role in immune phenomena
@nl
P2093
P3181
P1433
P1476
The properdin system and immun ...... d its role in immune phenomena
@en
P2093
P304
P3181
P356
10.1126/SCIENCE.120.3112.279
P407
P577
1954-08-20T00:00:00Z